Pinnacle Hill

Pinnacle Hill is a research and development company formed through a strategic partnership between the University of North Carolina at Chapel Hill and Deerfield Management. The entity is designed to bridge the gap between academic innovation and commercial drug development by providing funding and expertise to UNC-originated projects. Deerfield has committed up to $65 million to support the advancement of promising therapeutics from the laboratory toward clinical trials. The company focuses on diverse therapeutic areas, including oncology, neurology, and rare diseases, utilizing a project-based model to accelerate the delivery of new treatments to patients.